Showing results (71-80 of 76) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
Annals of Hematology|May 16, 2025
Polatuzumab Vedotin, zanubrutinib and rituximab (Pola-ZR) achieved rapid and deep response in untreated frail and elderly DLBCLYuhong Ren, Hui Tan, Jingli Zhuang, et al.
Cancer Medicine|August 19, 2025
Effectiveness and Safety of Polatuzumab Vedotin Plus an Anti-CD20 Monoclonal Antibody (Rituximab or Obinutuzumab) and Zanubrutinib in Relapsed/Refractory Diffuse Large B-Cell LymphomaYian Zhang, Yuhong Ren, Jingli Zhuang, et al.
Hematology (Amsterdam, Netherlands)|November 29, 2023
Clinical profiles in multiple myeloma patients with extreme survivals: a study from a National Medical Center in ChinaLiang Ren, Yuhong Ren, Yang Yang, et al.
British Journal of Haematology|February 28, 2023
Single-cell atlas of the immune microenvironment reveals macrophage reprogramming and the potential dual macrophage-targeted strategy in multiple myelomaJing Li, Yang Yang, Wenjing Wang, et al.
Leukemia & Lymphoma|June 11, 2020
The paradoxical prognostic role of 1q21 Gain/Amplification in multiple myeloma: every coin has two sidesJiadai Xu, Tianhong Xu, Yang Yang, et al.
Clinical and Experimental Medicine|January 13, 2023
A prognostic model incorporating inflammatory cells and cytokines for newly diagnosed multiple myeloma patientsLiang Ren, Jiadai Xu, Jing Li, et al.
Pageof 8